Improving the Lives of Patients, Supporting Entrepreneurs, and Earning the Trust of Investors Through Science, Strategy, and Innovation
Who We Are
RiverVest is a leading venture capital firm building life science companies to address significant unmet medical needs.
8Funds
Since 2000
- RiverVest Views
Portfolio Company Good Therapeutics Acquired by Roche, Launches Spinout Company Bonum Therapeutics
ST. LOUIS (September 7, 2022) – Good Therapeutics – a RiverVest Venture Fund IV portfolio company – has entered into a definitive merger agreement to be acquired by...
Read More
- RiverVest Views
Teleflex to Acquire Portfolio Company Standard Bariatrics
ST. LOUIS (August 22, 2022) – Standard Bariatrics – a RiverVest Venture Fund IV portfolio company – has entered into a definitive agreement to be acquired by Teleflex...
Read More28Commercial Products
Currently Treating Patients
RiverVest’s Footprint Increases Its Opportunity Set